Gilmour’s expected to join Argonaut in late January as a member of the firm’s senior leadership team and become a “meaningful” shareholder.

TORONTO - Canaccord Genuity Group Inc. says it has named former RBC executive Nadine Ahn as deputy chief financial officer, ...

Canaccord Genuity Group named Nadine Ahn as deputy chief financial officer. With the appointment, Ahn is set to succeed the Vancouver financial-services company's current CFO, Don MacFayden, who ...

Canaccord Genuity Group (TSX: CF) on Wednesday announced the appointment of Nadine Ahn as Deputy Chief Financial Officer, ...

Investment bank Canaccord Genuity Group on Wednesday appointed Nadine Ahn, Royal Bank of Canada's former finance chief who was terminated in April, as its deputy chief financial officer.

Canaccord Genuity Group Inc. hired former Royal Bank of Canada executive Nadine Ahn as deputy chief financial officer, with ...

Canaccord Genuity Group Inc. (TSX: CF) (the "Company") is pleased to announce the appointment of Nadine Ahn as Deputy Chief Financial Officer, Canaccord Genuity Group Inc.

George Gianarikas, an analyst from Canaccord Genuity, maintained the Hold rating on Surf Air Mobility, Inc. (SRFM – Research Report). The ...

Pathway Financial Advisors LLC lifted its position in shares of ServiceNow, Inc. (NYSE:NOW – Free Report) by 16.4% during the third quarter, HoldingsChannel reports. The fund owned 313 shares of the ...

在其他近期新闻中,BioXcel Therapeutics在运营和临床试验方面取得了重大进展。公司报告第二季度收入为110万美元,主要来自IGALMI的销售,超出预期。BioXcel还启动了名为SERENITY At-Home和TRANQUILITY In-Care的关键第3期试验,旨在评估BXCL501对双相障碍、精神分裂症和阿尔茨海默病患者的安全性和有效性。

在其他近期新闻中，10X Genomics报告2024年第二季度收益增加，总收入达到1.53亿美元，同比增长4%，环比增长9%。然而，由于仪器销售放缓，公司将全年收入指引下调至6.4亿美元至6.6亿美元之间。公司还宣布推出新的单细胞（SC）产品，包括"超大规模"选项和每个样本560美元的产品，作为降低成本策略的一部分。TD Cowen维持10X Genomics的持有评级，而Morgan ...

On Tuesday, Yeti Holdings Inc (YETI) stock saw a modest uptick, ending the day at $41.65 which represents a slight increase of $0.02 or 0.05% from the prior close of $41.63. The stock opened at $41.33 ...